Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Sam Dawbaa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Agents, Thiazoles, Drug Design, Morpholines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Anadolu University Scientific Research Project, Eskisehir, Turkey.
Abstract (Originalsprache)
Continuous efforts are carried out to find new cancer treatments. Compounds including thiazole or thiomorpholine rings showed favorable biological activities for various diseases including cancer. In this study, a new series of 4‐(4‐{[2‐(4‐phenylthiazol‐2‐yl)hydrazono]methyl}phenyl)thiomorpholine derivatives were synthesized and tested in vitro for their anticancer activity. Twelve compounds including various 4‐phenylthiazol and a single 4‐(2‐naphthyl)thiazole derivatives were synthesized and analyzed by 1 H‐nuclear magnetic resonance (NMR), 13 C‐NMR, and high‐resolution mass spectrometry (HRMS). The cytotoxic effects of the compounds were tested on the A549 lung cancer cell line and the L929 healthy cell line. Six compounds ( 3a , 3b , 3c, 3d , 3e , and 3f ) showed better inhibitory activity against A549 cells than the reference drug cisplatin. Compound 3f (4‐CH 3 phenyl derivative) was the most potent with an IC 50 of 3.72 µM. The cytotoxic activity against the healthy cell line L929 was evaluated and all of the tested compounds displayed IC 50 values of more than 500 µM, indicating a selectivity toward the cancer cell line A549. Activity against matrix metalloproteinase‐9 was also tested and the result indicated a %inhibition of 68.02 and 52.77 for compounds 3g and 3j , respectively. In silico evaluation was achieved via Density Functional Theory calculations and molecular dynamic simulations and the results were in line with those of the in vitro tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
- Department of Pharmacy, Faculty of Medical Sciences, Thamar University, Dhamar, Yemen.
- Department of Pharmacy Services, Vocational School of Health Services, Bilecik Şeyh Edebali University, Bilecik, Turkey.
- Faculty of Pharmacy, University of Business and Technology, Prishtina, Kosovo.
- Department of Biohemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Förderung
- Anadolu University Scientific Research Project, Eskisehir, Turkey
Zitieren
APA
Dawbaa, S., Evren, A. E., Nuha, D., Temel, H. E., Çiftçi, G. A., & Yurttaş, L. (2025). Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400821
Vancouver
Dawbaa S, Evren AE, Nuha D, Temel HE, Çiftçi GA, Yurttaş L. Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400821
BibTeX
@article{Dawbaa2025,
author = {Dawbaa, Sam and Evren, Asaf Evrim and Nuha, Demokrat and Temel, Halide Edip and Çiftçi, Gülşen Akalin and Yurttaş, Leyla},
title = {Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400821}
}
EUVIMED